Literature DB >> 8847231

Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes.

D S Monos1, M Kamoun, I A Udalova, E Csanky, B Cizman, R L Turetskaya, J B Smirnova, V G Zharkov, D Gasser, C M Zmijewski.   

Abstract

The TNF region within the MHC includes a number of immunologically important genes. Microsatellites TNFa and TNFb adjacent to TNF exhibit extensive polymorphism. Employing a PCR-based technique, we identified TNFab haplotypes and defined their distribution in 97 controls and 48 diabetics of Caucasoid origin in a search for other genes within the MHC potentially associated with IDDM. Twenty-five different TNFab haplotypes were identified. A significant difference (p < 0.0005) in frequency between patients and controls was found for TNFa1b5 (relative risk 53). However, no other TNFab microsatellites demonstrated significantly different frequencies. Among diabetics TNFa1b5 was found to be in linkage disequilibrium with HLA-DR3-B18, a haplotype known to be associated with IDDM. Thus the increased frequency of TNFa1b5 among diabetics could reflect a linkage disequilibrium with a gene within the TNF region or with other genes, including the HLAs, which characterize this haplotype. In both controls and diabetics TNFa2b3 and TNFa7b4 were in linkage disequilibrium with DR3-B8 and DR7, respectively. Among diabetics, TNFa2b1 and TNFa6b5 were in linkage disequilibrium with DR4-B62 and DR4-B44, respectively. It is intriguing that TNFab haplotypes, represented by a short piece of about 200 nucleotides in the untranslated region upstream of TNF beta gene, maintain strong linkage disequilibria with different HLA haplotypes extending over 1 million base pairs. The identification of TNFab microsatellites exhibiting a high polymorphic index in a region lacking known polymorphic markers may provide potentially important information regarding the association of HLA haplotypes with autoimmune diseases, as they are in close proximity to other genes of immunologic importance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847231     DOI: 10.1016/0198-8859(95)00060-h

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

Authors:  H W Schroeder; Z B Zhu; R E March; R D Campbell; S M Berney; S A Nedospasov; R L Turetskaya; T P Atkinson; R C Go; M D Cooper; J E Volanakis
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

2.  Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan.

Authors:  Sui-Foo Lo; Chung-Ming Huang; Mei-Chen Wu; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-05-16       Impact factor: 2.631

3.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

4.  The influence of tumor necrosis factor microsatellite polymorphisms on patient survival following hematopoietic stem cell transplantation.

Authors:  Katarina Stingl; Renata Zunec; Ranka Serventi-Seiwerth; Boris Labar; Zorana Grubić
Journal:  Croat Med J       Date:  2012-02-15       Impact factor: 1.351

5.  Is the association between TNF-alpha-308 A allele and DMT1 independent of HLA-DRB1, DQB1 alleles?

Authors:  Grazyna Deja; Przemysława Jarosz-Chobot; Joanna Polańska; Urszula Siekiera; Ewa Małecka-Tendera
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  HLA class I and class II associations with ESRD in Saudi Arabian population.

Authors:  Nuha Mahmoud Hamdi; Fadel Hassan Al-Hababi; Amr Ekhlas Eid
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.